Literature DB >> 6555044

The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.

C Parkes, J Gagnon, M A Kerr.   

Abstract

Human complement components C2 and Factor B each contain one free thiol group/molecule. Reaction with p-chloromercuribenzoate destroyed the haemolytic activity of C2 but had no effect on Factor B. Reaction of C2 with I2 gave a 16-fold enhancement of its haemolytic activity. The pH optimum for the reaction was 7.0. The I2 reacted at the thiol group in C2 with a stoicheiometry of 1 mol of I2/mol of C2. The product of the reaction was unaffected by millimolar concentrations of dithiothreitol; however, azide and cyanide were inhibitory. Reaction with azide did not result in re-expression of the thiol group. Mild oxidation of the thiol group with m-chloroperbenzoic acid did not enhance the haemolytic activity. The results suggest that reaction with I2 causes intramolecular covalent, but not disulphide, bond formation. I2 reacted with Factor B at the free thiol group without affecting the haemolytic activity. A CNBr-cleavage peptide from C2a (obtained by cleavage of C2 by subcomponent C1s) containing the free thiol group was isolated. Automated Edman degradation of the peptide showed that it was the N-terminal peptide of C2a. The free thiol group was identified at position 18.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6555044      PMCID: PMC1152109          DOI: 10.1042/bj2130201

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Chemical characterization of human factor B of the alternate pathway of complement activation.

Authors:  B Curman; L Sandberg-Trägårdh; P A Peterson
Journal:  Biochemistry       Date:  1977-11-29       Impact factor: 3.162

2.  The purification and properties of the second component of human complement.

Authors:  M A Kerr; R R Porter
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

3.  Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.

Authors:  S Nagasawa; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

4.  The alternative pathway C3/C5 convertase: chemical basis of factor B activation.

Authors:  P H Lesavre; T E Hugli; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

5.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

6.  Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (polybrene), and high pressure liquid chromatography.

Authors:  M W Hunkapiller; L E Hood
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

7.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

8.  The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathway.

Authors:  L W Mak; J Majewski; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

9.  Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

10.  Structural evidence that complement factor B constitutes a novel class of serine protease.

Authors:  J E Mole; M A Niemann
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

View more
  12 in total

1.  Isolation of cDNA clones for human complement component C2.

Authors:  D R Bentley; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

Review 2.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Effect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system.

Authors:  S Maeda; S Nagasawa
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

4.  Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.

Authors:  Kwok-Min Hui; George L Orriss; Tilman Schirmer; Bergljót Magnadóttir; Jürg A Schifferli; Jameel M Inal
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

5.  Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B.

Authors:  S C Williams; J Hinshelwood; S J Perkins; R B Sim
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

6.  Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A van Es
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

7.  The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.

Authors:  M A Kerr; C Parkes
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

8.  Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.

Authors:  M A Smith; M A Kerr
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

9.  Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.

Authors:  M B Villiers; N M Thielens; M G Colomb
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

10.  A genetic polymorphism of the complement component factor B in chickens not linked to the major histocompatibility complex (MHC).

Authors:  C Koch
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.